Nuvation Bio Inc. (NYSE:NUVB) is one of the Stocks to Buy Under $10 with High Potential. On January 15, Soumit Roy from JonesTrading reiterated a Buy rating on the stock and raised the price target from$10 to $12. Earlier, on January 13, Gregory Renza from Truist Financial also reiterated a Buy rating on Nuvation Bio Inc. (NYSE:NUVB) without disclosing any price targets. Analyst Roy from JonesTrading noted that his bullish sentiment is based on the upcoming data from a study of Safusidenib. It is an IDH ...